Retinoid Metabolism Is Altered in Human and Mouse Cicatricial Alopecia  by Everts, Helen B. et al.
Retinoid Metabolism Is Altered in Human and Mouse
Cicatricial Alopecia
Helen B. Everts1, Kathleen A. Silva2, Shalise Montgomery1, Liye Suo1, Monica Menser1, Amy S. Valet3,
Lloyd E. King3, David E. Ong4 and John P. Sundberg2,3
C57BL/6 mice develop dermatitis and scarring alopecia resembling human cicatricial alopecias (CAs), particularly
the central centrifugal CA (CCCA) type. To evaluate the role of retinoids in CA, the expression of retinoid
metabolism components were examined in these mice with mild, moderate, or severe CA compared with hair
cycle-matched mice with no disease. Two feeding studies were conducted with dams fed either NIH 31 diet
(study 1) or AIN93G diet (study 2). Adult mice were fed AIN93M diet with 4 (recommended), 28, or 56 IU vitamin
Ag 1 diet. Feeding the AIN93M diet to adults increased CA frequency over NIH 31 fed mice. Increased follicular
dystrophy was seen in study 1 and increased dermal scars in study 2 in mice fed the 28 IU diet. These results
indicate that retinoid metabolism is altered in CA in C57BL/6J mice that require precise levels of dietary vitamin A.
Human patients with CCCA, pseudopelade (end-stage scarring), and controls with no alopecia were also studied.
Many retinoid metabolism proteins were increased in mild CCCA, but were undetectable in pseudopelade.
Studies to determine whether these dietary alterations in retinoid metabolism seen in C57BL/6J mice are also
involved in different types of human CA are needed.
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INTRODUCTION
Vitamin A and its derivatives (retinoids) are important for
development and maintenance of multiple epithelial tissues
including skin, hair, and sebaceous glands, as severe, adverse
effects are seen in vitamin A deficiency or excess (Zouboulis,
2006; Smith and Thiboutot, 2008; Everts, 2012). Vitamin A is
stored in the liver and extrahepatic tissues as retinyl esters
(O’Byrne et al., 2005). Retinol bound to retinol-binding
protein 4 (RBP4) is the main circulating form of vitamin A
(Blaner et al., 2002) and maintained at a constant blood level
(Blomhoff et al., 1991). After a meal, some retinyl esters enter
nonhepatic tissues from circulating chylomicron remnants
(Blaner et al., 2002). Retinoic acid (RA) synthesis occurs
locally in or near cells that utilize it. Precise spatial and
temporal levels of RA in skin are achieved by regulating key
steps in cellular vitamin A metabolism: storage as retinyl
esters, RA synthesis, and RA degradation (Everts, 2012).
Retinol is transported into the cell through the protein called
stimulated by RA6 and binds cellular retinol-binding protein 1
(RBP1, aka CRBP). This bound retinol is either esterified by
lecithin:retinol acyltransferase for storage or reversibly oxi-
dized to retinal via retinol dehydrogenases (dehydrogenase
reductase (SDR family) member 9 (DHRS9), RDH10). Retinal
is further oxidized to RA by retinal dehydrogenases 1–3
(ALDH1A1–3). RA then moves to the nucleus bound to
cellular RA-binding protein 2 (CRABP2), binds to RA receptors
alpha, beta, and gamma (RARA, B, C) where it activates the
transcription of over 500 genes (Dong et al., 1999; Balmer and
Blomhoff, 2002). Retinyl ester hydrolases convert stored
retinyl esters back to retinol when needed (Blomhoff et al.,
1991; Gao and Simon, 2005).
When RBP1/CRBP is saturated or absent, retinol interacts
with different enzymes. Acyl CoA:diacylglycerol acyltransfer-
ase 1 (DGAT1) esterifies retinol for storage. Alopecia with
accelerated telogen to anagen transition was seen in basal epi-
dermis and outer root sheath specific (Krt14 cre) Dgat1tm2Far
null mice (Shih et al., 2009). This increased anagen induction
and alopecia was reduced in Dgat1tm2Far null mice by
severely reducing dietary vitamin A intake, indicating that
alopecia was due to excess retinol and RA. Free retinol can
also be oxidized by medium chain alcohol dehydrogenases
(ADH1, 3, and 4; current gene names Adh1, 5, and 7,
Duester, 2001). It has been argued by some (Kumar et al.,
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2012) and refuted by others (Napoli, 2012) that excess retinol
is oxidized to retinal by ADH1, and then to RA by ALDH1A1.
When given a toxic retinol dose, mice that lack Adh7tm1Gdu
(class IV, previously Adh4) have decreased retinol oxidation
in the kidney (Deltour et al., 1999a, b), but not in the liver
(Molotkov et al., 2002). These Adh7tm1Gdu null mice are also
more sensitive to vitamin A deficiency. ADH1 and ADH7
(class IV) are present in skin (unpublished observation,
Haselbeck et al., 1997), but their roles in skin have not been
studied.
RA is further metabolized by cytochrome P450 26 family
members (CYP26A1, B1, C1) with the assistance of cellular
RA-binding protein 1. Both Cyp26a1 and Cyp26b1 message
levels are RA inducible in both organotypic cultures and
human epidermis (Lorie et al., 2009a, b).
Primary cicatricial alopecias (CAs) are scarring hair loss
diseases with permanent hair loss because of destruction of
follicles and their stem cells by lymphocytic- and neutrophilic-
mediated inflammation (Bergfeld and Elston, 2003). Central
centrifugal CA (CCCA) is a progressive permanent alopecia
seen primarily in African-American women usually beginning
in their mid-30s, in an anterior vertex and mid-crown pattern.
C57BL/6J (B6) mice develop CA with similar characteristics as
patients with CCCA, including premature desquamation of the
inner root sheath and follicular dystrophy (Sperling and Sau,
1992; Sperling et al., 1994, 2000; Sperling, 2001; Sperling and
Cowper, 2006; Sundberg et al., 2011). In B6 mice, as the hair
shafts twist, they penetrate through the outer root sheath and
induce an inflammatory response. Studies in asebia-mutant
mice (ABJ/Le-Scd1ab-J/Scd1ab-J and DBA/1lacJ-Scd1ab-2J/
Scd1ab-2J) also suggest that the inflammatory response in CA
follows hair shaft penetration through the follicle (Sundberg
et al., 2000). Other theories for the cause of the various CAs
(McElwee, 2008) include: altered sebaceous gland function
with reduced sebum (Stenn et al., 1999; Sundberg et al., 2000;
Al-Zaid et al., 2011) and sebaceous gland duct inflammation
(Al-Zaid et al., 2011); reduced peroxisome proliferator–
activated receptor gamma and lipid metabolism (Karnik
et al., 2009); and hair follicle loss of immune privilege
(Harries et al., 2009).
Few studies have examined the role of diet in CA. Retinoid
supplementation improved CA in four patients with low serum
retinol levels (Kalz, 1958). As a result of this study and the
unique localization pattern of RA synthesis within the hair
follicle and sebaceous gland during the hair cycle (Everts
et al., 2007), the expression of retinoid metabolism proteins
were examined in the B6 mouse model of CA and human
patients with CA. The initial study reported that all substrains
of B6 mice had a polymorphism in Adh7, which reduced its
function (Dolney et al., 2001a, b), and only B6 substrains with
a higher frequency of disease had higher levels of DHRS9 in
telogen follicles (Sundberg et al., 2011). As CA in B6 mice
spared telogen follicles and only late anagen and catagen
follicles were affected, studies examined retinoid metabolism
in anagen hair follicles. The current report identifies RA
synthesis and signaling protein changes in both mouse and
human CA, and that modifying vitamin A intake modifies CA
severity in B6 mice.
RESULTS
RA synthesis, signaling, and degradation proteins were increased
in early/mild CA, but became undetectable in severe disease
The expression of retinoid synthesis components was previously
measured in telogen follicles of C57BL/6 mouse substrains
(Sundberg et al., 2011). The current study evaluated anagen
follicles, as it is the stage when B6 CA is most severe and RA
synthesis components peaked (Everts et al., 2007; Sundberg
et al., 2011). Biopsies of B6 mice that spontaneously devel-
oped CA in The Jackson Laboratory production facility were
evaluated by immunohistochemistry (IHC) using antibodies
against RBP1, DHRS9, ALDH1A1, ALDH1A2, ALDH1A3,
CRABP2, CYP26A1, RARA, and RARB. These mice were
grouped by severity of disease into no disease, mild, mode-
rate, or severe disease with hair follicles in mid-late anagen
using standard staging criteria (Muller-Rover et al., 2001).
Biopsies from human patients with CCCA, end-stage CA
(pseudopelade), and controls with no alopecia (tinea capitis
and follicles adjacent to pilar cysts) were also examined.
DHRS9 was increased in mild disease in mice and humans
with CCCA yet undetectable in severe disease (Figure 1,
Supplementary Figures S1 and S2 online). A similar pattern
of expression was also seen for ALDH1A1, ALDH1A2, and
RARB in mice and humans (Figure 2, Supplementary Figure S3
online, data not shown). CYP26A1 showed the same
pattern as well, but was only tested in mice (Figure 2;
Supplementary Figure S3 online). In moderate mouse CA,
levels of these proteins were similar to controls (data not
shown). In areas of dermal scars in mice, DHRS9 and
ALDH1A2 were high, but ALDH1A1 localized only to the
outer root sheath of telogen follicles and ALDH1A3 was not
altered (data not shown). CRABP2 IR also increased in mild
disease, but remained high within dystrophic hair follicles
in all disease states (Figure 3). RARA localization changed
with more RARA-positive cells seen in the dermis, espe-
cially surrounding the bulge in mild, moderate, and severe
mouse disease (Figure 3).
Dietary vitamin A altered the frequency and severity of CA in
B6 mice
To test the hypothesis that abnormal vitamin A metabolism is
one of the primary mechanisms causing CA in B6 mice, 12-
week-old female B6 mice (n¼ 9–10) were fed purified diets
containing one of the three levels of vitamin A (Research
Diets, New Brunswick, NJ). Diets contained either the Amer-
ican Institute of Nutrition (AIN; Reeves et al., 1993)
recommended level (4 IU g 1 diet), the highest level found
in a commercial diet used at The Jackson Laboratory (high;
28 IU g diet), or twice the highest level (excess; 56 IU g1).
Mice fed excess vitamin A had less alopecia than either of the
other groups, and all of these mice had significantly fewer hair
follicles in anagen, indicating that follicles were in their
normal telogen phase (Figure 4a and b). Histological analysis
showed that more hair follicle dystrophy occurred when hair
follicles were in anagen or catagen with an inverse correlation
between percent of hair follicle dystrophy and telogen follicles
(Figure 4c). Mice fed high vitamin A had more follicular
dystrophy and granulomas (Figure 4d and e).
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A second feeding study was conducted to test the hypoth-
eses that significantly lowering dietary vitamin A would
reduce the frequency and severity of CA. Typical mouse
commercial diets (chow) contain up to seven times the AIN
recommended level of dietary vitamin A (4 IU g1 diet,
Reeves et al., 1993). The chow diet fed to mice at The
Jackson Laboratory was analyzed and contained 6–28 IU
vitamin A g1 depending on the lot. This variability is
important as vitamin A is stored in the liver and dams fed
chow during breeding produce pups with large amounts of
vitamin A in their liver. Feeding dams a vitamin A-deficient
diet during breeding reduced liver stores of vitamin A in their
pups (Smith et al., 1987) and reduced alopecia in Dgat1tm2Far
null mice (Shih et al., 2009). To significantly lower vitamin A
levels in this study, dams were fed AIN93G diet for two
generations. This study also evaluated whether inducing
anagen by wax stripping would lead to CA but these hypo-
theses were incorrect. Alopecia was consistently high in all the
mice not wax stripped. However, wax stripping reduced the
frequency of alopecia in mice fed recommended and high
levels of vitamin A (Figure 4a). The one wax-stripped mouse
with alopecia fed the recommended diet developed signifi-
cantly more ulcers, dermal scars, and epidermal hyperplasia
than any other mouse in the study. The only other mice with
epidermal hyperplasia and dermal scars were the mice fed
high vitamin A in study 2 (Figure 4f). They also had signifi-
cantly less follicular dystrophy and granulomas than mice fed
the same diet in study 1 (Figure 4d and e, Po0.05). Within
study 2, mice fed high vitamin A had significantly lower
number of granulomas than mice fed recommended levels of
vitamin A (Figure 4e, Po0.05). This suggests that these mice
fed high vitamin A in study 2 had a previous bout of severe
disease.
Liver retinoid analysis revealed that dams fed the 4 IU diet
did not lower liver retinyl palmitate levels in their pups as
predicted (Figure 5b, Smith et al., 1987). Both liver retinol and
retinyl palmitate increased with dietary vitamin A as expected
(Figure 5a and b, Po0.001). Liver retinol was significantly
greater in the second study (Figure 5a, Po0.01). In addition,
wax stripping significantly reduced liver retinyl palmitate
levels (Figure 5b, Po0.01). Skin retinol increased with dietary
Figure 1. Immunoreactivity of dehydrogenase reductase (SDR family)
member 9 (DHRS9) increased in C57BL/6J mice with mild dermatitis and
biopsies from human patients with central centrifugal cicatricial alopecia
(CCCA), but was reduced in mice with severe disease and biopsies from
human patients with pseudopelade. Immunohistochemistry was performed
with an antibody against DHRS9 in dorsal skin from chow fed C57BL/6J inbred
mouse strain (B6) mice with no disease (a, n¼ 18), mild disease (c, n¼6),
severe disease (e, n¼ 38), biopsies from patients with no alopecia (b, normal
Caucasian skin adjacent to pilar cyst removed by excision n¼ 2, tinea capitus
from African-American skin n¼ 1), CCCA (d, n¼ 14), or pseudopelade
(f, n¼3). b and f are from Caucasian patients, whereas d is from an African-
American patient. Bar¼101mM for main picture and 10.1mM for insets.
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Figure 2. Overview of retinoid metabolism and how these proteins changed
during the progression of cicatricial alopecia. The left shows a schematic of
RA synthesis, degradation, and signaling pathways in B6 mice. The right shows
a summary of IHC results in chow fed B6 mice with no (control), mild,
moderate, or severe disease. Immunoreactivity intensity ranges from dark to
light; very strong (maroon), strong (red), moderate (hot pink), mild (pink), or
undetectable (white). ALDH1A1, 2, and 3, retinal dehydrogenase 1, 2, and 3;
B6, C57BL/6J inbred mouse strain; CL, companion layer; CRABP2, cellular
retinoic acid-binding protein II; CRBP, cellular retinol-binding protein;
CYP26A1, cytochrome P450 26 family member A1; DHRS9, dehydrogenase
reductase (SDR family) member 9; IHC, immunohistochemistry; Mod.,
moderate; PM, premedulla; RA, retinoic acid; RARA and B, retinoic acid
receptor alpha and beta.
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vitamin A in both the studies (Figure 5c, Po0.05). In mice fed
high vitamin A, skin retinol was greater in study 1 than in
study 2. This trend was seen when mice wax stripped and not
wax stripped were compared separately, but was significant
when all mice in study 2 fed high vitamin A were combined
(Figure 5c, Po0.05). There were no significant effects of pup
or dam diets on skin retinyl ester levels (Figure 5d). Skin retinyl
ester levels were significantly reduced in wax-stripped mice
(Figure 5c and d, Po0.05).
IHC analysis was performed to compare results from these
diet studies to those performed in NIH31 fed mice. RARB was
significantly reduced as the percentage of follicular dystrophy
increased (Supplementary Figures S4b, d and S5 online).
RARB was also low in dermal scars (Supplementary Figures
S4f and S5 online). In contrast, DHRS9 remained high in
dystrophic hair follicles, but dropped slightly in dermal scars
(Supplementary Figure S4a, c, e online). None of the mice in
these diet controlled studies had severe follicular dystrophy as
seen in NIH31 fed mice.
DISCUSSION
This study emphasizes that the effects of an essential nutrient,
vitamin A, must be tightly regulated to prevent adverse effects
because of excess or deficiency. In this study, both low and
high levels of dietary vitamin A given to B6 mice affected the
development and degree of follicular scarring, indicating that
precise control of retinoid metabolism is required for normal
function of hair follicles. Initial studies localized RA synthesis
and signaling proteins in normal mouse skin (Everts et al.,
2004, 2007). A subsequent study found that only B6 substrains
with a higher frequency of inflamed and follicular scarring had
higher levels of DHRS9 in telogen follicles (Sundberg et al.,
2011), suggesting a possible basis for their tendency to
develop CA. As CA occurs primarily during mid-late anagen,
the current study analyzed mid-late anagen hair follicles and
found that RA synthesis, degradation, and binding proteins
were altered during the progression of CA in B6 mice. These
proteins were increased in mild disease and reduced in severe
disease. A similar pattern of expression was also seen in
biopsies from patients with CCCA, although the full progres-
sion of disease was not obtained.
This study characterized changes in retinoid metabolism
throughout the entire progression of CA in a mouse model of
primary human CA. Others (Flowers et al., 2011) found at only
one time point Rbp1 (Crbp) and Crabp2 increased in skin
specific (Krt14-cre recombinase) Scd1tm2Ntam-null male B6
mice with mild CA. They also reported that several other
retinoid metabolism genes were increased in their microarray
analyses, but changes in expression of these genes were not
further validated at the message or protein level. They also
found that retinol, retinyl esters, and RA levels were increased
in the skin of these null mice. Feeding a vitamin A-deficient
diet did not reduce skin RA levels or change the phenotype,
arguing that the lack of Scd1 led to the increased skin RA
levels. In the current study, RA metabolism was altered in the
absence of a Scd1 mutation and significantly reducing dietary
vitamin A made the disease worse. These current studies
expand on the observations of Flowers et al. (2011) by
showing that as follicular dystrophy increases, the expression
of proteins responsible for RA synthesis and degradation begin
to decrease and reach undetectable levels in severe CA. This
observation was further confirmed by the reduction of RARB,
a classic RA target gene, as follicular dystrophy increased in
the two diet studies preceding the reduction of DHRS9. In
addition, these alterations in RA synthesis proteins were also
seen in biopsies from patients with CA. It is unknown at this
time whether altered RA synthesis and signaling caused the
alopecia or this alteration in retinoid metabolism is secondary
to the disease.
CYP26A1 also localized within the hair follicle and was
altered during CA. CYP26A1 was previously reported only in
basal keratinocytes, eccrine sweat glands, and sebaceous
glands (Heise et al., 2006). CYP26A1 has a key role in main-
taining RA levels through a feedback inhibitory loop (Reijntjes
et al., 2005). High levels of RA directly induce CYP26A1
expression (Loudig et al., 2000). Then CYP26A1 degrades this
excess RA. In addition, when RA levels are low, CYP26A1
levels are also low. In retinol dehydrogenase 1 (Rdh1tm1.1Jln)
null mice reduction in CYP26A1 expression compensated for
the reduced RA synthesis and maintained normal RA levels
(Zhang et al., 2007). These observations are consistent
with the concurrent alterations of CYP26A1 with DHRS9 in
this study.
Epigenetic silencing may explain the expression results
seen. Mutations in either CRABP2 or RARA resulted in
Figure 3. CRABP2 and retinoic acid receptor alpha (RARA) levels were
increased in C57BL/6J mice with cicatricial alopecia. Immunohistochemistry
was performed with antibodies against CRABP2 (a, c, e) and RARA (b, d, f),
in mice with no disease (a, b), mild disease (c, d), or severe disease (e, f).
Bar¼101mM for main picture and 10.1mM for insets.
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hypermethylation and epigenetic silencing of RARA target
genes such as RARB, CRBP, and CYP26A1 (Ren et al., 2005;
Corlazzoli et al., 2009; Laursen et al., 2012). As CRABP2
functions to deliver RA to RARA (Dong et al., 1999) and RARA
represses transcription in the absence of RA (Chen and Evans,
1995; Horlein et al., 1995), the above studies suggest that any
defect resulting in reduced RA binding to its receptor could
cause hypermethylation and gene silencing of RARA target
genes. Such defects would include reduced levels of RA
precursors retinol or retinyl esters, reduced uptake of retinol
or retinyl esters into the skin, reduced RA synthesis, reduced
delivery of RA to RARA via CRABP2, increased RA
degradation, or any defect in RARA itself. It is possible that
the reduction in RA synthesis enzymes, RARB, and CYP26A1
in moderate and severe CA, was because of this mechanism of
aberrant RA signaling induced hypermethylation. Alternatively,
a primary effect of increased dietary vitamin A could be
because of toxic effects during mild disease on specific hair
follicle cells, leading to their death or decreased biochemical
function such that the levels of RA synthesis enzymes and
receptors decrease as CA disease progresses. The current
studies indicate the balance between RA synthesis and
retinol degradation is altered in a mouse model of human
CA and imply that altered retinoid metabolism is involved in
the pathogenesis of CA. Future studies will determine whether
CA is because of altered retinoid metabolism or is because of
loss of retinoid related enzymes present in skin because of
scarring induced by another cause.
The current study implies that precise levels of dietary
vitamin A are required to compensate for the defects in
retinoid metabolism found in substrains of C57BL/6 mice.
A polymorphism in Adh7 (class IV, previously reported as
Adh4) was previously found in C57BL/6 mice that reduced its
function (Dolney et al., 2001a, b; Sundberg et al., 2011).
C57BL/6 mice have arginine120, whereas C3H/HeJ and other
strains of mice have cysteine120. Human ADH7 (class IV) also
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contains arginine120, similar to C57BL/6 mice (Kedishvili
et al., 1995). Additional polymorphisms in ADH7 (class IV)
were also found in humans linked to alcohol dependence,
heroin addiction, and reduced risk of head and neck
squamous cell carcinoma (Edenberg et al., 2006; Levran
et al., 2009; Wei et al., 2010). Polymorphisms in ADH7
(class IV) may predispose B6 mice and humans to CA. Studies
in transgenic mice suggest two roles for Adh7 (class IV).
Adh7tm1Gdu null mice have reduced fetal survival when dams
are deficient in vitamin A (Deltour et al., 1999a). When these
Adh7tm1Gdu null mice are stressed with excess retinol there
was reduced retinol clearance in the kidney (Deltour et al.,
1999a, b), but not the liver (Molotkov et al., 2002). These data
imply that reduced Adh7 (class IV) activity increase
susceptibility to both vitamin A deficiency and toxicity in B6
mice and some humans. This phenomenon may explain why
more severe disease was seen in the second study when dams
were fed lower vitamin A. The mice fed the AIN93G diet were
also slow to breed; the number of litters and the number of
pups per litter were decreased compared with chow fed mice.
These pups appeared runted at first, but appeared to catch up
their growth after several days. In addition, many of the dam’s
first litters were stillborn. It is possible that C57BL/6 mice
require a narrower window of vitamin A for optimal function
than other strains of mice. In the current study, this optimal
window is above 4 and below 28 IU vitamin A g1 of diet.
Variations in vitamin A levels in commercial unpurified diets
range from 6.2 to 28.7 IU in seven tests from two laboratories,
11.8–24.3 IU within the same lot (Sundberg unpublished data)
implying mixing is not uniform. In susceptible strains, this
variation in vitamin A concentration in commercial diets can
have a profound impact on the frequency of alopecia and
dermatitis, and explain the apparent randomness of CA
incidence in B6 mice in The Jackson Laboratory facility.
Humans with similar polymorphisms may also require more
precise levels of dietary vitamin A. Anecdotal reports suggest
reduced alopecia with retinyl palmitate supplementation
at roughly 3.5 times the recommended daily allowance
(8,000 IU day 1) in patients with low serum vitamin A
(Wilma Bergfeld, personal communication). Future studies
are needed to determine the optimal dose of vitamin A in
humans and mice susceptible to CA.
Retinoids are not the first treatment choice in CA patients,
but they do help some patients and are listed as a second or
third line of treatment in some forms of CA (Harries et al.,
2008). This variable benefit of retinoid therapy is similar to the
initial clinical trials in cancer (reviewed in, Freemantle et al.,
2003). It is now well established that retinoid resistance occurs
in cancer because of epigenetic hypermethylation of RARB
and other RA synthesis enzymes (Tang and Gudas, 2011).
Current studies combining low-dose retinoid treatment with
methyl transferase inhibitors in mouse models of cancer were
more successful (Tang et al., 2009). A similar situation of
retinoid resistance may occur in CA. If this is the case then this
dual treatment strategy may be worth testing for the treatment
of CA. As high vitamin A worsened CA in this mouse study,
this implies that pharmacological doses of retinoids may have
been toxic. High vitamin A intake (12 IU g1 diet) also
accelerated alopecia areata in graft-induced C3H/HeJ mice
(Duncan et al., 2012). Telogen effluvium was also seen in
patients treated with retinoids (Ruzicka et al., 1992). Thus, a
better treatment option may be to restore retinoid signaling
with methyl transferase inhibitors while maintaining adequate
dietary vitamin A levels. The exact ‘‘adequate’’ level of dietary
vitamin A is likely to be very different in mice and humans
with different genetic backgrounds.
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Figure 5. Dietary vitamin A altered liver and skin retinoids differently in the
various studies. Liver retinol (a), liver retinyl palmitate (b), skin retinol (c), and
skin retinyl esters (d) were analyzed by HPLC in study 1 (open bars, n¼ 9–10),
study 2 with no wax stripping (closed bars, n¼ 8–19), and study 2 with wax
stripping (hatched bars, n¼10–16). *Significant study effect (Po0.001 in a,
and Po0.05 in c), #significant effect of wax stripping (Po0.005), results with
different letters are significantly different from each other (Po0.05).
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In summary, this study suggests that retinoid metabolism is
altered in CA and high dietary vitamin A may worsen the
disease. Future studies are needed to determine whether the
changes observed occur in all primary lymphocytic and
neutrophilic forms of CA and the optimal level of dietary
vitamin A to prevent the occurrence and severity of human
CA. In B6 mice studies, the diet should start with 1.5–3 times
the recommended levels of vitamin A (6–12 IU g1 diet in B6
mice). This optimal level maybe different in different geno-
types, therefore future studies should analyze linkage between
Adh7 (class IV) single-nucleotide polymorphisms with CA.
As all substrains of B6 mice have Adh7 polymorphisms,
but differ in disease frequency, future studies should also
identify other genetic mutations in RA synthesis or signal-
ing genes. Epigenetic changes in retinoid metabolism in
CA should also be explored. In addition, RARB expression
levels may be a useful biomarker for severity of CA in
specific substrains of B6 mice and types of human CA. This
study also found that the frequency of this rare disease
could be increased by diet so that future studies can be
conducted in B6 mice to define the pathogenesis of CA and
develop specific treatments of human CA.
MATERIALS AND METHODS
Mice
The Jackson Laboratory (Bar Harbor, ME) Institutional Animal Care
and Use Committee approved all procedures and hair loss was
observed weekly. Hematoxylin and eosin slides of biopsies were
scored for specific follicle stage, follicular dystrophy, granulomas,
epidermal hyperplasia, ulcers, and dermal scars by a board certified
pathologist (JPS, Sundberg et al., 2008).
Initial expression study mice
Mice were fed the NIH 31 diet with 6% fat; (LabDiet 5K52, Purina
Mills, St Louis, MO) throughout the study. There were 51 female
controls. Cases were divided into mild (n¼ 6), moderate (n¼ 15),
severe (n¼ 38), and dermal scars (26). Hair follicles were staged as
anagen II–IIIc versus anagen IV–catagen I, and hair follicles in these
precise stages were compared between the groups (Muller-Rover
et al., 2001).
Diet study 1 mice
Dams and female pups were fed the NIH 31 diet until 12 weeks of
age, until switching to the AIN93 Maintenance (M) diet containing
4 (n¼ 9), 28 (n¼ 10), or 56 (n¼ 10) IU vitamin A g 1 diet (Research
Diets) for 4 months.
Diet study 2 mice
Dams were fed the AIN93 growth (G) diet throughout gestation.
Female pups from these dams were maintained on this AIN93G
diet during their growth phase and when they became pregnant.
Mice from this second generation of dams fed the AIN93G diet
were used in this study. At 6 weeks of age, these mice were fed
the AIN93M diet containing 4 (n¼ 19), 28 (n¼ 35), or 56 (n¼ 22)
IU vitamin A g 1 diet (Research Diets). At 16 weeks of age, mice
(n¼ 10, 4 IU; n¼ 16, 28 IU; n¼ 14, 56 IU) were depilated and then
euthanized 2 weeks later.
Human samples
Paraffin blocks of biopsies from 14 human patients with CCCA, 3
human patients with pseudopelade, and 3 nonalopecic dermatoses
(tinea capitus and skin adjacent to pilar cysts) were obtained with
Institutional Review Board approval from archives at Vanderbilt
University (Nashville, TN; Supplementary Table S1 online).
Procedures
IHC was performed as described previously (Everts et al., 2007).
Antibodies were purchased for CYP26A1 (Alpha Diagnostic Intl., San
Antonio, TX), RARA, and RARB (Santa Cruz Biotech, Santa Cruz, CA).
Other antibodies used were produced and validated in Dr Ong’s
laboratory (Everts et al., 2007). A blinded IHC score of RARB
immunoreactivity (IR) was measured using a scale of 0–4 multiplied
by the percentage of cells/mid-late anagen hair follicles. Two blinded
researchers scored human samples for % of cells and strength on a
0–4 scale with 0¼ no IR; 1¼ 1–25% cells, weak IR; 2¼ 26–50%
cells, moderate IR; 3¼ 51–75% cells, intense IR; 4¼ 76–100% cells,
very intense IR. The IHC level was calculated as the sum of intensity
plus % cells as previously validated (Shamonki et al., 2006).
Retinoids were extracted (Pappas et al., 1993) and analyzed by
HPLC with a modification of Fleshman et al., (2012) using a C18
4.6 100 mm, 3.5mM column. The solvents were (A) 80:20 MeOH/
0.1% formic acid and (B) MtBE. In all, 10–20ml of sample in 100% A
was injected and retinoids separated with initial conditions of
100%A, a linear gradient to 100%B over 13 minutes, held at
100%B for 3 minutes, then equilibrated back to 100%A over
2 minutes. Spectra were analyzed using a photodiode array (Agilent
Technologies, Santa Clara, CA) at 325 nm. Standards were purchased
from Sigma (St Louis, MO).
Chi-squared analysis was performed to determine differences in
hair loss using Prism 5 (Graph Pad; La Jolla, CA). All other data were
analyzed by analysis of variance, followed by Tukey post hoc tests
when appropriate using SPSS, v19 (IBM; Armonk, NY).
See Supplementary Data online for more detailed methods.
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